Page last updated: 2024-11-13

etimicin sulfate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID72710734
MeSH IDM0554504

Synonyms (9)

Synonym
d-streptamine, o-3-deoxy-4-c-methyl-3-(methylamino)-beta-l-arabinopyranosyl-(1->6)-o-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-d-erythro-hexopyranosyl-(1->4))-2-deoxy-n1-ethyl-, sulfate (salt)
etimicin sulfate
mc6xb22ugq ,
unii-mc6xb22ugq
d-streptamine, o-3-deoxy-4-c-methyl-3-(methylamino)-beta-l-arabinopyranosyl-(1->6)-o-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-d-erythro-hexopyranosyl-(1->4))-2-deoxy-n1-ethyl-, sulfate
d-streptamine, o-3-deoxy-4-c-methyl-3-(methylamino)-.beta.-l-arabinopyranosyl-(1->6)-o-(2,6-diamino-2,3,4,6-tetradeoxy-.alpha.-d-erythro-hexopyranosyl-(1->4))-2-deoxy-n1-ethyl-, sulfate
d-streptamine, o-3-deoxy-4-c-methyl-3-(methylamino)-.beta.-l-arabinopyranosyl-(1->6)-o-(2,6-diamino-2,3,4,6-tetradeoxy-.alpha.-d-erythro-hexopyranosyl-(1->4))-2-deoxy-n1-ethyl-, sulfate (salt)
etimicin sulfate [who-dd]
Q27283842

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" It was found to be a safe alternative for various severe infections."( Sub-acute toxicity study of a new aminoglycoside etimicin sulphate in swiss albino mice.
Chaudhary, M; Dwivedi, VK; Gupta, A; Payasi, A, 2010
)
0.36

Compound-Compound Interactions

ExcerptReferenceRelevance
"This paper describes an improved liquid chromatography method combined with pulsed electrochemical detection for the analysis of etimicin sulfate."( Improved liquid chromatography combined with pulsed electrochemical detection for the analysis of etimicin sulfate.
Adams, E; Deng, X; Fan, X; Hu, C; Wang, F; Wu, Y; Yuan, Y; Zhang, M; Zhao, W; Zhu, X, 2016
)
0.43
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (100.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (16.67%)4.05%
Observational0 (0.00%)0.25%
Other5 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]